Adaptogen review maps stress biology but leaves clinical benefits uncertain
The abstract combines laboratory and human research on plant extracts, with limited detail about clinical results or safety.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review describes how plant extracts may affect stress signaling and reports lower cortisol, less fatigue and better cognitive function in clinical studies. The abstract does not identify which extracts produced those outcomes or how consistent the results were. These reports cannot establish that a particular adaptogen product treats stress-related illness.
The abstract omits study counts, participant details, trial lengths and extract-specific effect estimates. Its claim that clinical studies reported no adverse effects comes without safety data that would allow readers to assess that conclusion.
What the review examined
The authors examined how plant compounds interact with stress-related signaling, hormone regulation and cellular protection. Their review brings together experiments in cells and animals, human trials and computer-based analyses, each addressing different kinds of questions.
Biological responses and clinical outcomes
Cortisol changes and altered cellular pathways describe biological responses. Fatigue and cognitive function are separate outcomes. The abstract reports favorable findings but does not link individual products, comparison groups or follow-up periods to those clinical outcomes.
The original publication
System-Level, Molecular and Cellular Mechanisms of Selected Plant Adaptogens-A Review.
Such S, Puchalski C, Kogut Ł et al.
Nutrients · 2026
- PubMed ID
- 41901106
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.